Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07562243 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Project PHOENIX: Molecular Signatures of Burn Pit Exposure

Study acronym: PHOENIX
StatusNot Yet Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Project PHOENIX is an observational clinical research study designed to characterize molecular, genomic, cellular, and functional features in blood specimens from former U.S. Service Members with prior burn pit exposure and from matched unexposed controls. Participants will complete screening, informed consent, health and exposure questionnaires, and a one-time blood collection. Blood-derived specimens may undergo genomic, epigenomic, transcriptomic, proteomic, metabolomic, immunophenotyping, and cellular functional analyses. Participants may also agree to optional future re-contact for health updates and possible repeat blood collection. The goal is to identify biologic signatures associated with prior deployment-related burn pit exposure and to support future biomarker discovery and translational research in veteran health.
Trial Details
NCT Number NCT07562243
Lead Sponsor Creative Medical Technology Holdings Inc
Collaborators: WCG IRB
Conditions
(from sponsor)		 Burn Pit Exposure, Airborne Hazard Exposure, Veteran Health, Deployment-Related Toxic Exposure, Biomarkers, Immune Dysfunction, Respiratory Symptoms
Related terms Immune System Diseases, Signs and Symptoms, Respiratory
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov